Aphelion Capital related stories
All articles and analysis
Data Spotlight: VC-backed M&A starts slow in new yearOnly five deals were disclosed in the month for a combined value of $615.5 million
Providence Medical Technology scores $12 mlnLafayette, California-based Providence Medical Technology Inc, a provider of cervical spine technology, has raised $12 million in funding. The investors included Stanmore Medical Investments and Aphelion Capital. Also, Silicon Valley Bank provided undisclosed debt financing. In addition to the funding, Providence Medical Technology has named Jason Hoffman as vice president of global sales.
- CyMedica Orthopedicts nabs $11.5 mln
Scottsdale, Arizona-based medical device company CyMedica Orthopedics has raised $11.5 million in Series A funding. Research Corporation Technologies Inc and California Technology Ventures LLC led the round with participation from other investors that included Aphelion Capital.
- BDC Venture Capital Healthcare Fund unveils advisory board
BDC Venture Capital Healthcare Fund, one of three sector-focused funds managed by the Business Development Bank of Canada, has established an advisory board to assist the fund in making investment decisions and driving growth in its portfolio companies. The board members are: Rod Altman, M.D., a physician who previously served at CMEA Capital and Aphelion Capital; Lisa Suennen, managing partner at Venture Valkyrie Consulting LLC; Jordan Shlain, M.D., a physician and founder of Healthloop; Craig Vercruysee, CEO of California Pacific Medical Center; and Stephen Dilly, CEO at Allergen Research Corp.
- Lighthouse Capital leads $2.5 mln round for iHear Medical
San Leandro, Calif-based hearing solutions provider iHear Medical has secured $2.5 million in funding. Lighthouse Capital led the round with participation from Aphelion Capital and Highlight Capital. In conjunction with the funding, Minglie Hu, a founding partner at Lighthouse Capital, has been added to iHear Medical's board of directors.
- Providence Medical Technology rakes in $6.8 mln Series C funds
Providence Medical Technology has received $6.8 million in Series C financing. Stanmore Medical Investments led the round with participation from Aphelion Capital and RCT Ventures. Also, Stanmore's David Cash and Aphelion's Ned Scheetz have been added to Providence's board of directors. Based in Lafayette, Calif., Providence Medical Technology is a medical device company focused on the cervical spine market.
- Providence Medical Technology rakes in $6.8 mln Series C funds
Providence Medical Technology has received $6.8 million in Series C financing. Stanmore Medical Investments led the round with participation from Aphelion Capital and RCT Ventures. Also, Stanmore's David Cash and Aphelion's Ned Scheetz have been added to Providence's board of directors. Based in Lafayette, Calif., Providence Medical Technology is a medical device company focused on the cervical spine market.
- VC-backed Corium files for IPO
Corium International has filed for an IPO. The number of shares that will be sold as well as the price range of the offering have yet to be set. Corium will trade its stock on the NASDAQ under the ticker symbol "CORI." Jefferies and Leerink Partners will serve as lead underwriters. Based in Menlo Park, Calif., Corium is a developer of advanced transdermal drug delivery technologies and products. It is backed by Essex Woodlands Health Ventures, Quantum Technology Partners and Aphelion Capital.
- Mercator MedSystems Closes $6.5 Mln Series B
Mercator MedSystems closed a $6.5 million Series B financing co-led by New York-based Volcano Capital and two San Francisco-based firms, Crocker Capital and Aphelion Capital. Washington D.C.-based Windy City Inc. and SET Technology Gmbh, a German-based investment fund, are also participating in the financing.
- CytoPherx Seals $34M
CytoPherx Inc., a developer of anti-inflammatory therapy for acute kidney injury, has raised $34 million in funding from Early Stage Partners, ONSET Ventures and Capital Midwest Fund. The money will be used to complete clinical trials and commercialize its therapy product. CytoPherx was founded in July 2007 and is based in Ann Arbor, Michigan.